Macular Amyloidosis. Other amyloidosis
Conditions
Interventions
Intervention 1: Intervention group: First, all patients who have the criteria to enter the Survey, informed i consent to participate in the study is obtaibed. Prior to treatment, any contamination is
Sponsors
Skin Research Center Of Shahid Beheshti Universiy Of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18-60 Confirming the diagnosis of macular amyloidosis by a dermatologist bilateral macular amyloidosis on trunk and extremities Patients with skin type 2_4 Fitzpatrick Filling out the informed consent form
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Past history of keloid formation Presence of active acne on site of macular amyloidosis Other skin disorders Hypersensitivity to lidocaine Application of other topical medications in the past month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement of pigmentation. Timepoint: first session and two weeks after final session. Method of measurement: comparison of photos by 2 dermatologist and fotofinder device.;Pigmentation pattern. Timepoint: first session and two weeks after final session. Method of measurement: checking for rippling.;Patient satisfaction. Timepoint: two weeks after final session. Method of measurement: asking the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Since 2weeks after starting of the treatment, till 2 weeks after the last session. Method of measurement: Asking the patient, examination by dermatologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Gheisari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed